Targeting B-Cell Maturation Antigen at Advanced Relapse in Multiple Myeloma

This activity is presented by Albert Einstein College of Medicine-Montefiore Medical Center in Collaboration with NACE

Summary

Multiple myeloma (MM) remains an incurable hematological malignancy that is characterized by clonal proliferation of malignant plasma cells in the bone marrow. Despite major advances in therapy for MM, most patients eventually relapse and become refractory to further treatment. Immunotherapy holds great promise for producing a more durable response, as it is capable of harnessing the patient's own immune system to attack and destroy tumor cells.

One of the most promising immunotherapeutic strategies in MM today involves B-cell maturation antigen, or BCMA. Because BCMA-targeted immunotherapies are expected to transform the MM treatment paradigm, this video-based activity reviews the latest research advances so that clinicians may continue providing optimal care for their patients.

 

Planning Committee
Sandy Bihlmeyer, M.Ed.
Senior Project Manager

 

Michelle Frisch, MPH, CHCP
Vice President, Operations

 

Daniela Hiedra
Associate Program Manager

 

Gregg Sherman, MD
Chief Medical Officer

 

Deborah Paschal, CRNP
Clinical Nurse Practitioner

Philadelphia, PA

 

Donald Harting MA, MS, ELS, CHCP

CME Content Development Specialist
Harting Communications LLC
Downingtown, PA

 

Peer Reviewer
Amit Verma, MBBS
Professor, Department of Medicine (Oncology)
Professor, Department of Developmental & Molecular Biology
Albert Einstein College of Medicine
Director, Division of Hemato-Oncology, Montefiore Department of Oncology
Bronx, NY

 

Policy on Faculty and Provider Disclosure

It is the policy of Albert Einstein College of Medicine-Montefiore Medical Center and NACE to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME/CE activities are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. The ACCME defines a commercial interest as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providing clinical service directly to patients to be commercial interests – unless the provider of the clinical service is owned, or controlled by, an ACCME-defined commercial interest. 

 

Disclosures

Dr. Gucalp has no relevant conflicts of interest with any ACCME-defined commercial interest.

Dr. Kornblum has no relevant conflicts of interest with any ACCME-defined commercial interest.

Accreditation Statement: CME Provider
In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Privacy

Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development protects the privacy of personal and other information regarding participants and educational collaborators. We will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting to the ACCME.

Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.

Additional information regarding Albert Einstein College of Medicine-Montefiore Medical Center's Privacy Policy can be viewed at https://www.mecme.org/PrivacyStatement.aspx.

COURSE VIEWING REQUIREMENTS